<DOC>
	<DOCNO>NCT00734097</DOCNO>
	<brief_summary>The purpose study assess patient gastro-oesophageal reflux disease ( heartburn ) currently receive treatment proton pump inhibitor still experience symptom benefit change treatment .</brief_summary>
	<brief_title>A Study Nexium ( Esomeprazole ) 40 mg Once Daily Subjects With Symptoms Gastroesophageal Reflux Disease ( GORD ) After Treatment With Full Dose Proton Pump Inhibitor ( PPI )</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Proton Pump Inhibitors</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Persisting symptom GORD despite previous treatment full dose proton pump inhibitor inform consent 18 year age Current course Proton Pump inhibitor treatment 8 week prior enrolment study More 1 course PPI treatment previous 12 month previous use esomeprazole presence alarm symptom</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>heartburn</keyword>
	<keyword>reflux</keyword>
	<keyword>proton</keyword>
	<keyword>pump</keyword>
	<keyword>inhibitor</keyword>
</DOC>